Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

117.07 +1.12 (+0.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,425,793
Open 117.34
Bid (Size) 116.71 (10)
Ask (Size) 117.06 (1)
Prev. Close 115.95
Today's Range 114.02 - 119.14
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens... 
Via Benzinga
Exposures COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes... 
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property

Performance

YTD
+4.06%
+4.06%
1 Month
-20.80%
-20.80%
3 Month
+12.99%
+12.99%
6 Month
+4.06%
+4.06%
1 Year
-3.83%
-3.83%

More News

Read More
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
Via Benzinga
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Via ACCESSWIRE
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With Moderna Stock Friday?
Via Benzinga
In-Depth Examination Of 10 Analyst Recommendations For Moderna
Via Benzinga
Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?
Via Benzinga
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
Via ACCESSWIRE
Silver Prices Fell To A 6-Week Low
Via Talk Markets
Topics Bonds Economy
Exposures Debt Markets Interest Rates
Moderna's Options: A Look at What the Big Money is Thinking
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today
Via Benzinga
Market Whales and Their Recent Bets on MRNA Options
Via Benzinga
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
Via Benzinga
2 Stocks Down More Than 30% to Buy Right Now
Via The Motley Fool
Exposures COVID-19
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dow Nearly 100 Points Lower Amid Slumping Home Sales
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Is Moderna Stock Trading Lower On Wednesday?
Via Benzinga
Exposures COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
Via Investor's Business Daily
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
S&P 500, Nasdaq Lurking Below Record Highs
Via Talk Markets
Topics Stocks
Exposures US Equities
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.